Item 8.01. Other Events.

On January 9, 2023, BIMI International Medical Inc.(the "Company") received formal notification from The Nasdaq Stock Market LLC confirming that the Company had regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Rule"), which requires that the Company's common stock maintain a minimum bid price of at least $1.00 per share, and that the matter is now closed.


                                       1

© Edgar Online, source Glimpses